Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
Submitted by
admin
on February 21, 2012 - 8:59am
Source:
TheStreet.com
News Tags:
Elan
Alzheimer's disease
bapineuzumab
monoclonal antibodies
Headline:
The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
Do Not Allow Advertisers to Use My Personal information
